PSI Careers Lunch & Learn: ChatGPT & Beyond

PSI Introduction to Industry Training (ITIT) Course - 2026/2027

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

AIMS SIG - Open-Source Lunch Bites

Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.

PSI Career Young Virtual Event (Q2 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Book Club: The AI Con – Joint with ASA Book Club

The Guardian described the authors of this book as refreshingly sarcastic! What is sold to us as AI, they announce, is just "a bill of goods": "A few major well-placed players are poised to accumulate significant wealth by extracting value from other people's creative work, personal data, or labour, and replacing quality services with artificial facsimiles."

Causal Inference SIG and EFSPI Methods Leaders: Modern Covariate Adjustment in Clinical Trials

This webinar will discuss modern approaches to covariate adjustment in clinical trials. We begin with the motivation and key principles underlying the FDA guidance, then revisit established methodologies in light of these regulatory considerations. Building on this foundation, we explore extensions to more advanced applications in clinical trial analysis. The webinar concludes with an outlook on future developments and a panel discussion.

PSI Book Club: Another Door Opens – Book Club Special Event

This is a Book Club Special Event in response to the changes in our industry and as a supportive move to create community and connection for those navigating redundancy and uncertainty. Read the book in advance of the book club session then join the zoom call to discuss ideas. There will be breakout groups to connect with others, exchange experiences of how the book has helped, and offer support.

PSI Book Club: Change: How organisations achieve hard-to-image results in uncertain and volatile times

Organizations have to adapt to the transforming landscape of our industry to ensure they continue to be successful in the future. Many of us are feeling the impact of organizational change. By reading John P Kotter’s book we can understand about organizational change and learn how to thrive, rather than just survive, through change. Change, by John P Kotter (and his team), is a summary of all that he has learned over his decades of research and leading change. His book describes why many current approaches to change are inadequate and explains why new solutions need to give people a voice and a role in a new, change-embracing organization. Develop your understanding of organisational change and become empowered to be part of your organisation’s change, by reading Change by John P Kotter and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply knowledge from the book in-between sessions.

PSI Career Young Virtual Event (Q3 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Training Course: Propensity Scores: Practical Application in Non-randomised Studies

The course will introduce the topic of propensity scores and the use of external data. Covering the topics of matching and weighting as well as more advance topics of high dimension propensity scores, multi-valued treatments, double robustness and time-varying scenarios. There will be the opportunity to participate in some hands on practical exercises in R.

PSI Career Young Virtual Event (Q4 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Speaker	Biography
Kleio Kipourou	Kleio is a pharmacist and biostatistician/data scientist with an extensive background in both academia and the pharmaceutical industry. Currently, she is working for GSK focusing on large scale projects that have complex challenges and require analytical solutions. Prior to her role at GSK, Kleio worked for AstraZeneca, where she successfully delivered a fully automated predictive tool for over 90 active clinical trials. This innovative tool not only ensured patient safety but also maximized trial success and significantly reduced cycle times. In addition, Kleio's commitment to promoting patient diversity and addressing the impact of socioeconomic inequalities on health outcomes led her to engage in extensive research under the sponsorship of Cancer Research UK. During this time, she developed novel methods that quantify individuals risks as well as differences in cancer survival. Through her contributions, Kleio has played an essential role in advancing our understanding of these disparities and their implications for cancer patients. Presently, Kleio is leading an exciting initiative at GSK that emphasizes the ethical use of statistical models and AI. This initiative not only raises awareness but also provides essential recommendations to ensure the responsible and ethical implementation of cutting-edge technologies in pharma.
Andy Nicholls	Andy Nicholls has been a Data Scientist for as long as people started calling themselves Data Scientists. He currently serves as the Head of Data Science at GSK Biostatistics' Statistics and Data Science Innovation Hub. In this role, he leads a team dedicated to developing data science capabilities within Biostatistics and providing innovative Data Science solutions for R&D business partners in areas such as Clinical Operations, Resource Management, HR, and Finance. Before re-joining GSK in 2017, Andy held the position of Head of Data Science Consultancy at Mango Solutions, a specialised data science consultancy with a focus on the R programming language. During his tenure at Mango, he supervised various consultancy projects across multiple sectors, delivered technical training, and implemented a wide range of technical solutions, from simple analytics to extensive IoT projects. Andy's professional background also includes experience as a clinical trial statistician at GSK. He holds an MMath in Mathematics from the University of Bath and an MSc in Statistics with Applications in Medicine from the University of Southampton.
Tom Fisher	Tom is a machine learning researcher at UCB, where he one of his roles involves working as part of a team exploring the utilisation of large language models (LLMs) within the company. After studying maths at Cambridge, he pursued an MSc in Machine Learning from UCL, where he published a paper on gender bias in LLMs. During his time as a research associate at Oxford, he focused on applying machine learning techniques to remote sensing in international development before shifting his focus to electronic health records. This involved investigating the potential of BERT-like models to enhance cardiovascular disease risk prediction. In his spare time, Tom enjoys sports and music.

Other Careers Events